IB 
Union Calendar No. 580 
115TH CONGRESS 
2D SESSION 
H. R. 5590 
[Report No. 115–746, Part I] 
To require the Secretary of Health and Human Services to provide for 
an action plan on recommendations for changes under Medicare and 
Medicaid to prevent opioids addictions and enhance access to medication- 
assisted treatment, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 24, 2018 
Mr. KINZINGER (for himself, Ms. CLARKE of New York, Mr. LAHOOD, and 
Mr. DANNY K. DAVIS of Illinois) introduced the following bill; which was 
referred to the Committee on Energy and Commerce, and in addition to 
the Committee on Ways and Means, for a period to be subsequently de-
termined by the Speaker, in each case for consideration of such provisions 
as fall within the jurisdiction of the committee concerned 
JUNE 12, 2018 
Additional sponsors: Mrs. BLACKBURN, Mr. WALDEN, and Mr. MITCHELL 
JUNE 12, 2018 
Reported from the Committee on Energy and Commerce with an amendment 
[Strike out all after the enacting clause and insert the part printed in italic] 
JUNE 12, 2018 
The Committee on Ways and Means discharged; committed to the Committee 
of the Whole House on the State of the Union and ordered to be printed 
[For text of introduced bill, see copy of bill as introduced on April 24, 2018] 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6652
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
A BILL 
To require the Secretary of Health and Human Services 
to provide for an action plan on recommendations for 
changes under Medicare and Medicaid to prevent opioids 
addictions and enhance access to medication-assisted 
treatment, and for other purposes. 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Opioid Addiction Action 
Plan Act’’. 
SEC. 
2. 
ACTION 
PLAN 
ON 
RECOMMENDATIONS 
FOR 
CHANGES UNDER MEDICARE AND MEDICAID 
TO PREVENT OPIOIDS ADDICTIONS AND EN-
HANCE ACCESS TO MEDICATION-ASSISTED 
TREATMENT. 
(a) IN GENERAL.—Not later than January 1, 2019, 
the Secretary of Health and Human Services (in this sec-
tion referred to as the ‘‘Secretary’’), in collaboration with 
the Pain Management Best Practices Inter-Agency Task 
Force convened under section 101(b) of the Comprehensive 
Addiction and Recovery Act of 2016 (Public Law 114–198), 
shall develop an action plan that provides recommendations 
described in subsection (b). 
(b) ACTION PLAN COMPONENTS.—Recommendations 
described in this subsection are, based on an examination 
by the Secretary of potential obstacles to an effective re-
sponse to the opioid crisis, recommendations, as determined 
appropriate by the Secretary, on the following: 
(1) Recommendations on changes to the Medicare 
program under title XVIII of the Social Security Act 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6203
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
and the Medicaid program under title XIX of such 
Act that would enhance coverage and payment under 
such programs of all medication-assisted treatment 
approved by the Food and Drug Administration for 
the treatment of opioid addiction and other therapies 
that manage chronic and acute pain and treat and 
minimize risk of opioid addiction, including rec-
ommendations on changes to the Medicare prospective 
payment system for hospital inpatient department 
services under section 1886(d) of such Act (42 U.S.C. 
1395ww(d)) and the Medicare prospective payment 
system for hospital outpatient department services 
under section 1833(t) of such Act (42 U.S.C. 1395l(t)) 
that would allow for separate payment for such thera-
pies, if medically appropriate and if necessary to en-
courage development and adoption of such therapies. 
(2) Recommendations for payment and service 
delivery models to be tested by the Center for Medicare 
and Medicaid Innovation and other federally author-
ized demonstration projects, including value-based 
models, that may encourage the use of appropriate 
medication-assisted treatment approved by the Food 
and Drug Administration for the treatment of opioid 
addiction and other therapies that manage chronic 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6203
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
and acute pain and treat and minimize risk of opioid 
addiction. 
(3) Recommendations for data collection that 
could facilitate research and policy making regarding 
prevention of opioid addiction and coverage and pay-
ment under the Medicare and Medicaid programs of 
appropriate opioid addiction treatments. 
(4) Recommendations for policies under the 
Medicare program and under the Medicaid program 
that can expand access for rural, or medically under-
served communities to the full range of medication-as-
sisted treatment approved by the Food and Drug Ad-
ministration for the treatment of opioid addiction 
and other therapies that manage chronic and acute 
pain and treatment and minimize risk of opioid ad-
diction. 
(5) Recommendations on changes to the Medicare 
program and the Medicaid program to address cov-
erage or payment barriers to patient access to med-
ical devices that are non-opioid based treatments ap-
proved by the Food and Drug Administration for the 
management of acute pain and chronic pain, for 
monitoring substance use withdrawal and preventing 
overdoses of controlled substances, and for treating 
substance use disorder. 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6203
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
(c) STAKEHOLDER MEETINGS.— 
(1) IN GENERAL.—Beginning not later than 3 
months after the date of the enactment of this Act, the 
Secretary shall convene a public stakeholder meeting 
to solicit public comment on the components of the ac-
tion plan recommendations described in subsection 
(b). 
(2) PARTICIPANTS.—Participants of meetings de-
scribed in paragraph (1) shall include representatives 
from the Food and Drug Administration and Na-
tional Institutes of Health, biopharmaceutical indus-
try members, medical researchers, health care pro-
viders, the medical device industry, the Medicare pro-
gram, the Medicaid program, and patient advocates. 
(d) REQUEST FOR INFORMATION.—Not later than 3 
months after the date of the enactment of this section, the 
Secretary shall issue a request for information seeking pub-
lic feedback regarding ways in which the Centers for Medi-
care & Medicaid Services can help address the opioid crisis 
through the development of and application of the action 
plan. 
(e) REPORT TO CONGRESS.—Not later than June 1, 
2019, the Secretary shall submit to Congress, and make 
public, a report that includes— 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6203
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
(1) a summary of recommendations that have 
emerged under the action plan; 
(2) the Secretary’s planned next steps with re-
spect to the action plan; and 
(3) an evaluation of price trends for drugs used 
to reverse opioid overdoses (such as naloxone), includ-
ing recommendations on ways to lower such prices for 
consumers. 
(f) DEFINITION
OF MEDICATION-ASSISTED TREAT-
MENT.—In this section, the term ‘‘medication-assisted treat-
ment’’ includes opioid treatment programs, behavioral ther-
apy, and medications to treat substance abuse disorder. 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6203
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS
Union Calendar No. 580 
115TH CONGRESS 
2D SESSION 
H. R. 5590 
[Report No. 115–746, Part I] 
A BILL 
To require the Secretary of Health and Human 
Services to provide for an action plan on rec-
ommendations for changes under Medicare and 
Medicaid to prevent opioids addictions and en-
hance access to medication-assisted treatment, 
and for other purposes. 
JUNE 12, 2018 
Reported from the Committee on Energy and Commerce 
with an amendment 
JUNE 12, 2018 
The Committee on Ways and Means discharged; com-
mitted to the Committee of the Whole House on the 
State of the Union and ordered to be printed 
VerDate Sep 11 2014 
01:04 Jun 13, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6651
Sfmt 6651
E:\BILLS\H5590.RH
H5590
pbinns on DSK79D2C42PROD with BILLS